Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marie‐Charlotte Laude"'
Autor:
Amine Belhabri, Mael Heiblig, Stephane Morisset, Liliana Vila, Clémence Santana, Emmanuelle Nicolas‐Virelizier, Sandrine Hayette, Isabelle Tigaud, Adriana Plesa, Hélène Labussiere‐Wallet, Mohamad Sobh, Anne‐Sophie Michallet, Balsat Marie, Franck‐Emmanuel Nicolini, Yann Guillermin, Fossard Gaëlle, Laure Lebras, Philippe Rey, Lucie Jauffret‐Bertholon, Marie‐Charlotte Laude, Loron Sandrine, Mauricette Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16929-16944 (2023)
Abstract Background t‐AML occurs after a primary malignancy treatment and retains a poor prognosis. Aims To determine the impact of primary malignancies, therapeutic strategies, and prognostic factors on clinical outcomes of t‐AML. Results A tota
Externí odkaz:
https://doaj.org/article/5ada555af80042d89c8cd782e7628bd6
Autor:
Charles Dumontet, Delphine Demangel, Perrine Galia, Lionel Karlin, Laurent Roche, Mathieu Fauvernier, Camille Golfier, Marie‐Charlotte Laude, Xavier Leleu, Philippe Rodon, Murielle Roussel, Isabelle Azaïs, Chantal Doyen, Borhane Slama, Salomon Manier, Olivier Decaux, Maroulio Pertesi, Marie Beaumont, Denis Caillot, Eileen M. Boyle, Manuel Cliquennois, Pascale Cony‐Makhoul, Anne‐Violaine Doncker, Véronique Dorvaux, Marie Odile Petillon, Jean Fontan, Bénédicte Hivert, Isabelle Leduc, Cécile Leyronnas, Margaret Macro, Michel Maigre, Clara Mariette, Philippe Mineur, Sophie Rigaudeau, Bruno Royer, Laure Vincent, James Mckay, Emeline Perrial, Laurent Garderet
Publikováno v:
American Journal of Hematology
American Journal of Hematology, 2023, 98 (2), pp.264-271. ⟨10.1002/ajh.26785⟩
American journal of hematology, Vol. 98, no.2, p. 264-271 (2023)
American Journal of Hematology, 2023, 98 (2), pp.264-271. ⟨10.1002/ajh.26785⟩
American journal of hematology, Vol. 98, no.2, p. 264-271 (2023)
International audience; Familial forms of monoclonal gammopathy, defined as multiple myeloma (MM) or Monoclonal Gammopathy of Undetermined Significance (MGUS), are relatively infrequent and most series reported in the literature describe a limited nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb8f2444f93c53edcfc2b2d1ed87766
https://univ-rennes.hal.science/hal-03980698
https://univ-rennes.hal.science/hal-03980698
Autor:
Clémentine Nicod, Mathieu Neto da Rocha, Walid Warda, Xavier Roussel, Rafik Haderbache, Evan Seffar, Rim Trad, Lucie Bouquet, Mathieu Goncalves, Léa Bosdure, Marie-Charlotte Laude, Mélanie Guiot, Christophe Ferrand, Marina Deschamps
Publikováno v:
Current Research in Translational Medicine. 71:103385
Autor:
Arsène Vacherot, Emmanuel Beillard, Catherine Chassagne-Clément, Marie-Charlotte Laude, Pierre Sesques, Laure Lebras, Alexandra Traverse-Glehen, Claire Mauduit, Mauricette Michallet, Stéphane Morisset, Anne-Sophie Michallet, Yann Guillermin
Publikováno v:
Blood. 140:11878-11879
Autor:
Violaine Safar, Emmanuelle Nicolas-Virelizier, Lionel Karlin, Alexandra Traverse-Glehen, Catherine Chassagne-Clément, Gabriel Brisou, Anne Lazareth, Fadhela Bouafia, Gabriel Antherieu, Youenn Drouet, François Ducray, David Meyronet, Emmanuel Bachy, Emmanuelle Ferrant, Hervé Ghesquières, Edith Julia, Pierre Sesques, Gilles Salles, Camille Golfier, Marie-Charlotte Laude, Dana Ghergus, Helene Lequeu, Philippe Rey
Publikováno v:
Blood. 136:43-45
Background: Diagnostic-to-treatment interval (DTI) was recently described as a strong prognostic factor for newly diagnosed systemic diffuse large B-cell lymphoma patients (DLBCL) with an improvement of event-free survival (EFS) for patients with a l
Autor:
Franck Morschhauser, Laure Lebras, Paul Coppo, Fabien Subtil, Bénédicte Deau-Fischer, Lucile Bussot, Charles Bescond, Thérèse Aurran-Schleinitz, Hervé Ghesquières, Simon Favre, Amira Marouf, Bénédicte Burlet, Cédric Rossi, Sandrine Malot, Xavier Roussel, Emmanuel Gyan, Sylvain Carras, Laurianne Drieu La Rochelle, Marianne Schwarz, Anne-Sophie Michallet, Roza Chin, Adrien Daniel, Romain Guieze, Thierry Lamy De La Chapelle, Pierre Sesques, Carolyne Croizier, Marie-Charlotte Laude, Krimo Bouabdallah, Adrien Chauchet
Publikováno v:
American Journal of Hematology
American Journal of Hematology, 2020, 96 (3), pp.302-311. ⟨10.1002/ajh.26068⟩
American Journal of Hematology, 2020, 96 (3), pp.302-311. ⟨10.1002/ajh.26068⟩
International audience; Historically, double or triple hit lymphoma (DHL and THL) have poor outcomes with conventional chemotherapy, but there is currently no guideline. We report the French experience in managing DHL and THL in first line using coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f275d0ab01d3b4f66a8e8668641935a2
https://www.hal.inserm.fr/inserm-03823000
https://www.hal.inserm.fr/inserm-03823000
Autor:
Walid Warda, Léa Bosdure, Lucie Bouquet, Christophe Ferrand, Marie-Charlotte Laude, Marina Deschamps, Melanie Guiot, Rafik Haderbache, Xavier Roussel, Clémentine Nicod, Rim Trad, Mathieu Neto Da Rocha
Publikováno v:
Transfusion Clinique et Biologique. 28:S4
Autor:
Fadhela Bouafia, Emmanuelle Nicolas-Virelizier, François Ducray, Helene Lequeu, Marie-Charlotte Laude, Alexandra Traverse-Glehen, Youenn Drouet, Anne Lazareth, Gabriel Brisou, David Meyronet, Gabriel Antherieu, Pierre Sesques, Hervé Ghesquières, Philippe Rey, Gilles Salles, Dana Ghergus, Emmanuelle Ferrant, Camille Golfier, Edith Julia, Emmanuel Bachy, Catherine Chassagne-Clément, Violaine Safar, Lionel Karlin
Publikováno v:
Blood. 136:6-7
Introduction Primary cerebral lymphoma (PCNSL) is an uncommon subtype of diffused large B-cell lymphoma (DLBCL) with a particular poor outcome as compared to systemic DLBCL, especially in elderly. For patients older than 60 years, standard treatment
Autor:
Gilles Salles, Caroline Le Jeune, Maël Heiblig, Marie-Charlotte Laude, Eric Wattel, Xavier Thomas, Alexandre Deloire, Mohamed Elhamri
Publikováno v:
European Journal of Haematology
European Journal of Haematology, Wiley, 2017, 98, pp.134-141. ⟨10.1111/ejh.12811⟩
European Journal of Haematology, Wiley, 2017, 98, pp.134-141. ⟨10.1111/ejh.12811⟩
Objective Little data exist regarding long-term survival in elderly patients with acute myeloid leukemia (AML). Methods In view of the fact that most deaths occurred during the first three years, the present study examined long-term survival in this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5883ae7a69d4e983dd2aef256e969c
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01795724
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01795724